Search for an orphan drug

*(*) mandatory field

Other search option(s)

Marketing authorisation without orphan designation - Europe

Therapeutic indication

As monotherapy for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma (UC): after prior platinum containing chemotherapy, or who are considered cisplatin ineligible, and whose tumours have a PD-L1 expression >= 5%

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.